86 reports of this reaction
1.9% of all FLUVOXAMINE MALEATE reports
#9 most reported adverse reaction
HEADACHE is the #9 most commonly reported adverse reaction for FLUVOXAMINE MALEATE, manufactured by ANI Pharmaceuticals, Inc.. There are 86 FDA adverse event reports linking FLUVOXAMINE MALEATE to HEADACHE. This represents approximately 1.9% of all 4,575 adverse event reports for this drug.
Patients taking FLUVOXAMINE MALEATE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for FLUVOXAMINE MALEATE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for FLUVOXAMINE MALEATE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 86 FDA reports for FLUVOXAMINE MALEATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 1.9% of all adverse event reports for FLUVOXAMINE MALEATE, making it a notable side effect.
If you experience headache while taking FLUVOXAMINE MALEATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.